These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 1483669)

  • 1. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
    Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
    Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial.
    Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K
    Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate endoscopic injection therapy of bleeding oesophageal varices: a prospective comparative evaluation of injecting materials in Egyptian patients with portal hypertension.
    Omar MM; Fakhry SM; Mostafa I
    J Egypt Soc Parasitol; 1998 Apr; 28(1):159-68. PubMed ID: 9617052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: Polidocanol Foam Versus Liquid Ethanolamine Oleate.
    Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
    AJR Am J Roentgenol; 2015 Sep; 205(3):659-66. PubMed ID: 26295655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic sclerotherapy in a rat model of esophageal varices.
    Nishida R; Inoue R; Takimoto Y; Hamashima H; Kita T
    Scand J Gastroenterol; 1995 May; 30(5):489-96. PubMed ID: 7638578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ethanolamine and polidocanol in the eradication of esophageal varices. A prospective randomized trial.
    Balanzó J; Sainz S; Espinós JC; Such J; Segura J; Guarner C; Cussó X; Vilardell F
    Endoscopy; 1989 Nov; 21(6):251-3. PubMed ID: 2693076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices.
    Iso Y; Kitano S; Iwanaga T; Koyanagi N; Sugimachi K
    Endoscopy; 1988 Nov; 20(6):285-8. PubMed ID: 3229387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.
    Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K
    Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.
    Lux G; Retterspitz M; Stabenow-Lohbauer U; Langer M; Altendorf-Hofmann A; Bozkurt T
    Endoscopy; 1997 May; 29(4):241-6. PubMed ID: 9255525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol.
    Nishida R; Inoue R; Takimoto Y; Kita T
    J Gastroenterol Hepatol; 1999 May; 14(5):481-8. PubMed ID: 10355514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices.
    Thakeb F; Salama Z; Salama H; Abdel Raouf T; Abdel Kader S; Abdel Hamid H
    Endoscopy; 1995 Jun; 27(5):358-64. PubMed ID: 7588349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices:--a prospective randomized trial.
    Iso Y; Kawanaka H; Tomikawa M; Matsumata T; Kitano S; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):467-71. PubMed ID: 9164520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices.
    Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K
    J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate.
    Neeman A; Leiser A; Kadish U
    Am J Gastroenterol; 1991 Sep; 86(9):1182-4. PubMed ID: 1882797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: a prospective randomized study.
    Umehara M; Onda M; Tajiri T; Toba M; Yoshida H; Yamashita K
    Gastrointest Endosc; 1999 Jul; 50(1):7-12. PubMed ID: 10385714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
    Tsutsumi M; Takada A
    Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate.
    Kitano S; Koyanagi N; Iso Y; Higashi H; Sugimachi K
    Hepatology; 1987; 7(5):810-5. PubMed ID: 3498673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic injection sclerotherapy for esophagogastric variceal bleeding in children with biliary atresia.
    Horigome H; Nomura T; Saso K; Hashimoto T; Suzuki T; Joh T; Ohara H; Akita S; Sobue S; Mizuno Y; Kato Y; Ohmi H; Itoh M
    Hepatogastroenterology; 1999; 46(30):3060-2. PubMed ID: 10626160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial of schedules for sclerosing esophageal varices. 1-versus 2-week intervals.
    Higashi H; Kitano S; Hashizume M; Yamaga H; Sugimachi K
    Hepatogastroenterology; 1989 Oct; 36(5):337-40. PubMed ID: 2695448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy.
    Ohta M; Hashizume M; Ueno K; Tanoue K; Sugimachi K
    Hepatogastroenterology; 1993 Feb; 40(1):65-8. PubMed ID: 8462932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.